Pulse Oximetry Racial Bias

Pulse oximeters which inaccurately read the oxygen of darker skinned individuals can be used by medical professionals to make decisions about access to care as seen in some instances of COVID-19.  

​

The racial bias in pulse oximeters, where the devices may overestimate blood oxygen levels in individuals with darker skin tones, can have significant medical and public health implications. These include:

1. Delayed or Missed Diagnosis

• Hypoxemia (low oxygen levels in the blood) can go undetected in patients with darker skin tones because pulse oximeters may provide falsely high readings.

• This can result in delays in initiating life-saving treatments, such as oxygen therapy or mechanical ventilation.

2. Inequities in Care

• Patients with undiagnosed or underestimated hypoxemia may receive less aggressive treatment or be deprioritized for care.

• These inaccuracies can exacerbate existing health disparities, particularly in respiratory conditions like COVID-19, asthma, or chronic obstructive pulmonary disease (COPD).

3. Worsened Clinical Outcomes

• Inaccurate readings can lead to under-treatment, which may result in poorer health outcomes, such as organ damage, prolonged illness, or even death, especially in acute conditions like pneumonia or sepsis.

4. Disparities in Research and Trials

• Clinical trials and studies relying on pulse oximetry for patient monitoring might inadvertently include inaccurate data for participants with darker skin tones, skewing results and potentially leading to ineffective or biased medical guidelines.

5. Erosion of Trust

• Recognition of racial bias in medical devices like pulse oximeters can undermine trust in healthcare systems, particularly among historically underserved populations.

6. Economic and Systemic Costs

• Misdiagnosis or delayed care can increase healthcare costs due to longer hospital stays, more intensive interventions, or litigation related to inadequate treatment.

Addressing the Bias

Efforts to address this issue include:

• Improving the design and calibration of pulse oximeters to ensure accuracy across all skin tones.

• Educating clinicians about the limitations of these devices and encouraging supplemental methods for assessing oxygen levels.

• Implementing policies that require more rigorous testing of medical devices in diverse populations.

The goal is to mitigate these biases to ensure equitable healthcare for all patients.